Research & Development
Noninvasive Ventilator Obtains EUA from the FDA for At-Home Use for the Treatment of COVID-19
11 August 2020 - - US-based medical technology company Nanotronics's Nanotronics Health, LLC subsidiary has obtained Emergency Use Authorization from the US Food and Drug Administration for its non-invasive ventilator, nHale, for at-home use, the company said.

Nanotronics Health, LLC, also received authorization for the nHale to be used with supplemental oxygen under a doctor's prescription.

As knowledge of the disease progresses, medical professionals and the public have become aware of how crucial non-invasive ventilation is for COVID-19 patient care in the hospital and beyond.

To meet this need, Nanotronics Health, LLC, leveraged Nanotronics' deep in-house expertise, incorporating advanced AI, Intelligent Factory Control and sophisticated engineering to conceive, design and manufacture the noninvasive ventilator in under 90 days.

nHale is accessible to patients at a fraction of the cost of other noninvasive ventilators. With a one-button approach, the device is designed for quality, comfort, and ease of use.

Nanotronics Health, LLC, developed and designed nHale to assist spontaneously breathing adults suffering from COVID-19 disease.

It is intended for use in non-life-threatening situations, such as a patient in need of breathing assistance but not in need of invasive ventilatory support based on standard medical protocols.

Nanotronics Health, LLC is a subsidiary of and powered by Nanotronics. The company uses Intelligent Factory Control to build and scale medical devices that are affordable, accessible and well-designed.

Our first product, nHale, a non-invasive ventilator, was conceived, built, and obtained Emergency Use Authorization by the FDA within 90 days to treat patients suffering from COVID-19.

After obtaining Emergency Use Authorization, Nanotronics immediately began producing and shipping devices.

The nHale is a bi-level positive air pressure device to support respiratory therapy of spontaneously breathing adults weighing over 30kg suffering from COVID-19 disease.

It is a non-invasive ventilator designed to be used in non-life-threatening situations, for spontaneously breathing patients, such as a patient in need of breathing assistance but not in need of invasive ventilatory support based on standard medical protocols.

The machine is for use in traditional healthcare facilities (e.g., hospitals, assisted living facilities, nursing homes) as well as spaces converted for the care of large numbers of COVID-19 patients (e.g., convention centers, university dormitories, motels, etc.).

The nHale is also intended for use in home settings with a doctor's prescription.

Supplemental oxygen may be used with the nHale device to increase the oxygen concentration of the airflow being delivered to the patient only when prescribed and trained by a qualified medical professional.

The warnings must be observed when using supplemental oxygen with the nHale device.
Nanotronics Health LLC, a subsidiary of Nanotronics, applied Nanotronics' deep in-house expertise, incorporating advanced AI, Intelligent Factory Control, and sophisticated engineering to build a machine that is easily manufactured at scale and at a reduced cost to increase accessibility for all Americans.

The nHale device is designed for comfort and ease-of-use with the simplicity of one button.
nHale has been authorized by FDA under an Emergency Use Authorization [EUA]; nHale is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of the device; nHale has not been FDA cleared or approved.
Login
Username:

Password:


Related Headlines